Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Bitcoin mining company Bitfarms reported a net loss of $27 million in the second quarter of 2024

Bitcoin mining company Bitfarms reported a net loss of $27 million in the second quarter of 2024

Bitget2024/08/11 22:51

Bitfarms reported a net loss of $27 million, a decrease of 16% or $0.07 per share sequentially, which included a $1 million non-cash charge for the reassessment of warrant liabilities for the 2021 and 2023 financing activities. This compares to a net loss of $6.0 million, or $0.02 per share, in the first quarter of 2024, which included a $9.0 million non-cash gain on the reassessment of the warrant liability. This decrease is attributable to a reduction in block rewards as a result of the April 19, 2024 BTC halving event.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

SQM.US Q3 profit misses expectations; lithium price declines but demand outlook remains “encouraging”

SQM.US still reports seeing "encouraging" potential demand trends.

智通财经•2026/11/18 03:16

Mizuho: Consecutive system outages in the US trigger stockpiling surge! With short-term demand boosted, Costco (COST.US) sales momentum is expected to remain strong.

According to a report by Mizuho Securities analysts, following a series of recent system failures in the United States, consumers have started stockpiling essential goods, leading to a short-term surge in demand for Costco, a members-only retailer.

智通财经•2026/11/18 03:07
Mizuho: Consecutive system outages in the US trigger stockpiling surge! With short-term demand boosted, Costco (COST.US) sales momentum is expected to remain strong.

Biogen (BIIB.US) announces mid-stage trial data for early Alzheimer's candidate drug diranersen: significant slowing of clinical decline over two years

Biogen has released the latest interim clinical trial data for its early-stage Alzheimer's disease candidate drug, diranersen.

智通财经•2026/11/18 03:02
Biogen (BIIB.US) announces mid-stage trial data for early Alzheimer's candidate drug diranersen: significant slowing of clinical decline over two years

Nvidia Acting CEO Kress Reassures the Market: No Customer Loss and No Employee Exodus

Nvidia released its first quarterly financial report since Jensen Huang's resignation, after which Colette Kress told the media that major client demand has not been affected and the workforce remains stable, emphasizing that "everything is business as usual." The company's share price rose over 3% after hours, though the stock is still down 24% for the month.

华尔街见闻•2026/11/18 02:41